IN2014MN02526A - - Google Patents

Info

Publication number
IN2014MN02526A
IN2014MN02526A IN2526MUN2014A IN2014MN02526A IN 2014MN02526 A IN2014MN02526 A IN 2014MN02526A IN 2526MUN2014 A IN2526MUN2014 A IN 2526MUN2014A IN 2014MN02526 A IN2014MN02526 A IN 2014MN02526A
Authority
IN
India
Prior art keywords
medicament
core
active ingredient
provision
intermediate layer
Prior art date
Application number
Other languages
English (en)
Inventor
Gernot Francas
Karl Heinz PRZYKLENK
Original Assignee
Hennig Arzneimittel Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hennig Arzneimittel Gmbh & Co filed Critical Hennig Arzneimittel Gmbh & Co
Publication of IN2014MN02526A publication Critical patent/IN2014MN02526A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN2526MUN2014 2012-06-25 2013-06-24 IN2014MN02526A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012105528.9A DE102012105528A1 (de) 2012-06-25 2012-06-25 Arzneiform zur Freisetzung von Wirkstoffen
PCT/EP2013/063162 WO2014001267A2 (fr) 2012-06-25 2013-06-24 Forme galénique pour la libération de principes actifs

Publications (1)

Publication Number Publication Date
IN2014MN02526A true IN2014MN02526A (fr) 2015-07-17

Family

ID=48656002

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2526MUN2014 IN2014MN02526A (fr) 2012-06-25 2013-06-24

Country Status (20)

Country Link
EP (2) EP2679216B1 (fr)
AU (1) AU2013283473B2 (fr)
BR (1) BR112014032578B1 (fr)
CA (1) CA2877190C (fr)
CO (1) CO7250447A2 (fr)
DE (1) DE102012105528A1 (fr)
DK (1) DK2679216T3 (fr)
EA (1) EA030871B1 (fr)
ES (2) ES2607447T3 (fr)
HU (2) HUE031246T2 (fr)
IL (1) IL236466B (fr)
IN (1) IN2014MN02526A (fr)
MX (1) MX367284B (fr)
MY (1) MY168531A (fr)
PH (1) PH12014502836B1 (fr)
PL (2) PL2679216T3 (fr)
PT (2) PT2863896T (fr)
UA (1) UA118836C2 (fr)
WO (1) WO2014001267A2 (fr)
ZA (1) ZA201409506B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2936748C (fr) 2014-10-31 2017-08-08 Purdue Pharma Methodes et compositions destinees au traitement du trouble de deficit d'attention
DK3431078T3 (da) 2017-07-20 2021-04-19 Intas Pharmaceuticals Ltd Orale faste betahistinsammensætninger med ikkepulserende forlænget frigivelse
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
DE102018129419A1 (de) 2018-11-22 2020-05-28 Johannes Gutenberg-Universität Mainz Acrylat-Copolymer für galenische Anwendungen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
IT1229237B (it) * 1989-05-08 1991-07-26 Prodotti Formenti Sali di (2-(piridil)etil) metilammina
DE59308333D1 (de) * 1992-08-06 1998-05-07 Gergely Gerhard Leicht einnehmbare brausende Manteltablette
HRP970493A2 (en) 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
IT1309591B1 (it) 1999-03-05 2002-01-24 Formenti Farmaceutici Spa Composizioni a rilascio controllato di betaistina.
DE10010509A1 (de) 2000-03-08 2001-09-13 Dresden Arzneimittel Pharmazeutische Formulierungen
DE10104880A1 (de) 2001-01-31 2002-08-08 Roehm Gmbh Multipartikuläre Arzneiform, enthaltend mindestens zwei unterschiedlich überzogene Pelletformen
PT1493435E (pt) * 2003-07-04 2008-08-14 Formenti Farmaceutici Spa Composições de libertação controlada de beta-histina
US20060280795A1 (en) * 2005-06-08 2006-12-14 Dexcel Pharma Technologies, Ltd. Specific time-delayed burst profile delivery system
ES2400964T3 (es) * 2007-04-04 2013-04-15 Sigmoid Pharma Limited Composiciones famacéuticas de ciclosporina
US20130323309A1 (en) * 2011-02-17 2013-12-05 Lupin Limited Sustained Release Composition of Memantine

Also Published As

Publication number Publication date
PT2679216E (pt) 2015-10-09
EP2863896B1 (fr) 2016-09-14
PH12014502836A1 (en) 2015-02-02
EA201500044A1 (ru) 2015-05-29
PL2863896T3 (pl) 2017-04-28
CO7250447A2 (es) 2015-04-30
PH12014502836B1 (en) 2015-02-02
DE102012105528A1 (de) 2014-01-02
UA118836C2 (uk) 2019-03-25
AU2013283473B2 (en) 2016-10-27
WO2014001267A2 (fr) 2014-01-03
IL236466A0 (en) 2015-02-26
ZA201409506B (en) 2016-08-31
EP2679216B1 (fr) 2015-05-27
MX2014015660A (es) 2015-07-14
ES2546172T3 (es) 2015-09-21
IL236466B (en) 2019-02-28
MX367284B (es) 2019-08-13
HUE025739T2 (en) 2016-04-28
PT2863896T (pt) 2016-12-21
AU2013283473A2 (en) 2015-01-22
DK2679216T3 (en) 2015-08-31
ES2607447T3 (es) 2017-03-31
BR112014032578B1 (pt) 2022-07-26
MY168531A (en) 2018-11-12
EP2679216A1 (fr) 2014-01-01
CA2877190C (fr) 2020-01-07
CA2877190A1 (fr) 2014-01-03
EP2863896A2 (fr) 2015-04-29
BR112014032578A2 (pt) 2017-06-27
AU2013283473A1 (en) 2015-01-29
EA030871B1 (ru) 2018-10-31
HUE031246T2 (en) 2017-06-28
WO2014001267A3 (fr) 2014-03-06
PL2679216T3 (pl) 2015-12-31

Similar Documents

Publication Publication Date Title
MX2019007956A (es) Liberacion autorregulada de ingrediente farmaceutico activo.
MX350875B (es) Formas de dosificacion farmaceutica de liberacion controlada.
WO2013158680A3 (fr) Compositions et méthodes comprenant du célécoxib ou composés apparentés et du dextrométhorphane
IN2014DN10548A (fr)
PH12020550806A1 (en) Core tablet composite preparation comprising mosapride and rabeprazole
PH12014501408A1 (en) Immediate release multi unit pellet system
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
PH12014502836B1 (en) Medicament form for release of active ingredients
WO2013058484A3 (fr) Composé diterpène de type ingénane et composition pharmaceutique pour le traitement ou la prévention de maladies infectieuses virales le contenant
PH12015500653B1 (en) Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
MX2011007779A (es) Formulaciones galenicas de compuestos organicos.
MX2016008027A (es) Uso de laquinimod para retrasar la evolucion de la enfermedad de huntington.
WO2016108572A3 (fr) Composition visant à prévenir et à traiter les maladies liées au cholestérol
WO2012102645A3 (fr) Composition pharmaceutique peptidique, agents à base de cette composition pour le traitement de troubles gastroduodénaux induits par helicobacter pylori, et procédé d'utilisation
UA108277C2 (ru) Комплексный препарат, содержащий лерканидипина гидрохлорид и валсартан, и способ его получения
MX2017013633A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas.
TW201613606A (en) Therapeutic drug for chronic renal failure
WO2014129884A3 (fr) Composition présentant un effet inhibiteur sur l'activité de l'intégrase virale
WO2012111961A3 (fr) Comprimé à libération prolongée, administré par voie orale, contenant de la tianeptine ou un sel pharmaceutiquement acceptable de celle-ci
JP2013079218A5 (fr)
WO2012033348A3 (fr) Composition pour la prévention ou le traitement de maladies allergiques comprenant du 2-linoléoyl glycérol
WO2013035053A3 (fr) Procédé inédit de transport de médicaments, facilité par un processus de conjugaison, à travers la barrière hémato-encéphalique
CN302482373S (zh) 药品包装盒(辛伐他汀胶囊)
WO2013169977A3 (fr) Forme pharmaceutique solide à libération contrôlée